Who owns ABEONA THERAPEUTICS INC?
- Ticker: ABEO
- CUSIP Number: 00289y206
Tip: Access positions for across all investors
Analyze quarterly positions in Abeona Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Abeona Therapeutics stock
Who bought or sold ABEONA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Adage Capital Partners GP | 3.2M | $14M | 85% | Sep 2023 |
|
Nantahala Capital Management | 2.8M | $14M | 18% | Dec 2023 |
|
Millennium Management | 1.4M | $7.1M | 37% | Dec 2023 |
|
Vanguard Group | 1.1M | $5.5M | 46% | Dec 2023 |
|
Western Standard | 808k | $4.0M | 261% | Dec 2023 |
|
AIGH Capital Management | 788k | $3.9M | -31% | Dec 2023 |
|
Point72 Asset Management | 761k | $3.8M | -36% | Dec 2023 |
|
Ikarian Capital | 600k | $3.0M | 100% | Dec 2023 |
|
Citigroup | 450k | $2.3M | 0% | Dec 2023 |
|
J. Goldman & Co | 430k | $2.2M | -13% | Dec 2023 |
|
Geode Capital Management | 197k | $829k | 25% | Sep 2023 |
|
Worth Venture Partners | 196k | $984k | -30% | Dec 2023 |
|
Walleye Trading Advisors | 188k | $942k | 100% | Dec 2023 |
|
Barclays | 170k | $850k | -54% | Dec 2023 |
|
Knott David M Jr | 160k | $674k | 0% | Sep 2023 |
|
BlackRock | 141k | $593k | -1% | Sep 2023 |
|
Citadel Advisors | 110k | $553k | 100% | Dec 2023 |
|
Northern Trust | 109k | $457k | 5% | Sep 2023 |
|
Susquehanna International | 87k | $367k | 100% | Sep 2023 |
|
Alyeska Investment Group | 70k | $351k | 100% | Dec 2023 |
|
Two Sigma Investments | 57k | $285k | 100% | Dec 2023 |
|
State Street Corporation | 51k | $215k | 0% | Sep 2023 |
|
Bank of America Corporation | 51k | $256k | 100% | Dec 2023 |
|
Marshall Wace | 48k | $240k | 100% | Dec 2023 |
|
Jane Street | 41k | $205k | 100% | Dec 2023 |
|
Jump Financial | 40k | $199k | 100% | Dec 2023 |
|
Renaissance Technologies | 31k | $130k | -8% | Sep 2023 |
|
LPL Financial | 25k | $103k | 100% | Sep 2023 |
|
CI Private Wealth | 14k | $70k | 0% | Dec 2023 |
|
Bank of New York Mellon | 13k | $67k | 3% | Dec 2023 |
|
Tower Research Capital | 10k | $44k | 100% | Sep 2023 |
|
Squarepoint Ops | 10k | $50k | 100% | Dec 2023 |
|
Group One Trading | 10k | $42k | 100% | Sep 2023 |
|
Simplex Trading | 4.8k | $23k | -66% | Dec 2023 |
|
Morgan Stanley | 4.7k | $20k | 0% | Sep 2023 |
|
Advisor Group Holdings | 2.6k | $13k | -2% | Dec 2023 |
|
Royal Bank of Canada | 1.0k | $4.8k | 14314% | Dec 2023 |
|
Hartford Financial Management | 720.00 | $3.6k | 0% | Dec 2023 |
|
Parallel Advisors | 400.00 | $2.0k | 0% | Dec 2023 |
|
Wells Fargo & Company | 237.00 | $1.2k | 41% | Dec 2023 |
|
Rhumbline Advisers | 58.00 | $290.000000 | 0% | Dec 2023 |
|
Truvestments Capital | 51.00 | $215.000700 | 0% | Sep 2023 |
|
Jpmorgan Chase & Co | 14.00 | $70.000000 | 0% | Dec 2023 |
|
Highlander Capital Management | 1.00 | $5.000000 | 0% | Dec 2023 |
|
Who sold out of Abeona Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Schonfeld Strategic Advisors | Sep 2023 | 154k | $648k |
Creative Planning | Sep 2023 | 14k | $59k |
GSA Capital Partners | Sep 2023 | 12k | $49k |
Dimensional Fund Advisors | Sep 2023 | 11k | $47k |
UBS Group | Sep 2023 | 1.1k | $4.5k |
FMR | Jun 2023 | 16.00 | $64.000000 |
Cambridge Trust Company | Sep 2023 | 13.00 | $55.000400 |